{"id":535128,"date":"2021-09-07T16:09:42","date_gmt":"2021-09-07T20:09:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/"},"modified":"2021-09-07T16:09:42","modified_gmt":"2021-09-07T20:09:42","slug":"marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/","title":{"rendered":"Marker Therapeutics to Present at Three Upcoming September Investor Conferences"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">HOUSTON<\/span>, <span class=\"xn-chron\">Sept. 7, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0<u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3282100-1&amp;h=2797309951&amp;u=https%3A%2F%2Fna01.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Furldefense.proofpoint.com%252Fv2%252Furl%253Fu%253Dhttps-3A__markertherapeutics.com_%2526d%253DDwMFAg%2526c%253DZQs-KZ8oxEw0p81sqgiaRA%2526r%253D7Fcu04uyu6z8vHMRvsocYA%2526m%253DWpRa1Hgrt95IILAsLqgroUygOWEG43b_mUGuFD7NAtw%2526s%253DQNeMZG_z8AtyieG5LZsAPbgdftUycVu_SfZKyip79fA%2526e%253D%26data%3D02%257C01%257C%257Cdf8a2623ac1042a3f1c208d696b402f3%257C4eb559913abc42a1a045430fc690a419%257C0%257C0%257C636862097243236330%26sdata%3DkSDBzpgFQWelmNjrDrSp0BbydP3H82n%252BgYMSoi%252BHtvw%253D%26reserved%3D0&amp;a=Marker+Therapeutics%2C+Inc.\" rel=\"nofollow noopener\">Marker Therapeutics, Inc.<\/a><\/u>\u00a0(NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that the Company will present at three upcoming virtual investor conferences in September.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/771253\/Marker_Therapeutics_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/771253\/Marker_Therapeutics_Logo.jpg\" title=\"Marker Therapeutics, Inc. (PRNewsfoto\/Marker Therapeutics, Inc.)\" alt=\"Marker Therapeutics, Inc. (PRNewsfoto\/Marker Therapeutics, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>Conference Details<\/b>\n      <\/p>\n<p>\n        <b>H.C. Wainwright Annual Global Investment Conference<br \/><\/b>Company Presenter: <span class=\"xn-person\">Anthony H. Kim<\/span>, Chief Financial Officer<br \/>Date: <span class=\"xn-chron\">Monday, September 13, 2021<\/span><br \/>Time: On-demand beginning at <span class=\"xn-chron\">7:00 a.m. ET<\/span><\/p>\n<p>\n        <b>Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit<br \/><\/b>Company Presenter: <span class=\"xn-person\">Mythili Koneru<\/span>, M.D., Ph.D., Chief Medical Officer<br \/>Date: <span class=\"xn-chron\">Wednesday, September 22, 2021<\/span><br \/>Time: <span class=\"xn-chron\">9:05 a.m. ET<\/span><\/p>\n<p>\n        <b>Cantor Fitzgerald Global Healthcare Conference<br \/><\/b>Fireside Chat <br \/>Date: <span class=\"xn-chron\">Monday, September 27, 2021<\/span><br \/>Time: <span class=\"xn-chron\">10:40 a.m. ET<\/span><\/p>\n<p>Live webcasts of the presentations will be accessible from the Investors section of the company&#8217;s website at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3282100-1&amp;h=2392292856&amp;u=https%3A%2F%2Fwww.markertherapeutics.com%2F&amp;a=markertherapeutics.com\" rel=\"nofollow noopener\">markertherapeutics.com<\/a>\u00a0and will be available for replay following the event.<\/p>\n<p>\n        <b>About Marker Therapeutics, Inc.<br \/><\/b>Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker&#8217;s cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens (i.e. tumor targets) and kill tumor cells expressing those targets. This population of T cells is designed to attack multiple tumor targets following infusion into patients and to activate the patient&#8217;s immune system to produce broad spectrum anti-tumor activity. Because Marker does not genetically engineer its T cell therapies, we believe that our product candidates will be easier and less expensive to manufacture, with reduced toxicities, compared to current engineered CAR-T and TCR-based approaches, and may provide patients with meaningful clinical benefit. As a result, Marker believes its portfolio of T cell therapies has a compelling product profile, as compared to current gene-modified CAR-T and TCR-based therapies.<\/p>\n<p>To receive future press releases via email, please visit: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3282100-1&amp;h=998170349&amp;u=https%3A%2F%2Fwww.markertherapeutics.com%2Femail-alerts&amp;a=https%3A%2F%2Fwww.markertherapeutics.com%2Femail-alerts\" rel=\"nofollow noopener\">https:\/\/www.markertherapeutics.com\/email-alerts<\/a>.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=SF98273&amp;sd=2021-09-07\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences-301370677.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences-301370677.html<\/a><\/p>\n<p>SOURCE  Marker Therapeutics, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=SF98273&amp;Transmission_Id=202109071605PR_NEWS_USPR_____SF98273&amp;DateId=20210907\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire HOUSTON, Sept. 7, 2021 \/PRNewswire\/ &#8212;\u00a0Marker Therapeutics, Inc.\u00a0(NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that the Company will present at three upcoming virtual investor conferences in September. Conference Details H.C. Wainwright Annual Global Investment ConferenceCompany Presenter: Anthony H. Kim, Chief Financial OfficerDate: Monday, September 13, 2021Time: On-demand beginning at 7:00 a.m. ET Oppenheimer Fall Healthcare Life Sciences &amp; MedTech SummitCompany Presenter: Mythili Koneru, M.D., Ph.D., Chief Medical OfficerDate: Wednesday, September 22, 2021Time: 9:05 a.m. ET Cantor Fitzgerald Global Healthcare ConferenceFireside Chat Date: Monday, September 27, 2021Time: 10:40 a.m. ET Live webcasts of the presentations will be accessible from the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Marker Therapeutics to Present at Three Upcoming September Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-535128","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Marker Therapeutics to Present at Three Upcoming September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Marker Therapeutics to Present at Three Upcoming September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire HOUSTON, Sept. 7, 2021 \/PRNewswire\/ &#8212;\u00a0Marker Therapeutics, Inc.\u00a0(NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that the Company will present at three upcoming virtual investor conferences in September. Conference Details H.C. Wainwright Annual Global Investment ConferenceCompany Presenter: Anthony H. Kim, Chief Financial OfficerDate: Monday, September 13, 2021Time: On-demand beginning at 7:00 a.m. ET Oppenheimer Fall Healthcare Life Sciences &amp; MedTech SummitCompany Presenter: Mythili Koneru, M.D., Ph.D., Chief Medical OfficerDate: Wednesday, September 22, 2021Time: 9:05 a.m. ET Cantor Fitzgerald Global Healthcare ConferenceFireside Chat Date: Monday, September 27, 2021Time: 10:40 a.m. ET Live webcasts of the presentations will be accessible from the &hellip; Continue reading &quot;Marker Therapeutics to Present at Three Upcoming September Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-07T20:09:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/771253\/Marker_Therapeutics_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Marker Therapeutics to Present at Three Upcoming September Investor Conferences\",\"datePublished\":\"2021-09-07T20:09:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\\\/\"},\"wordCount\":342,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/771253\\\/Marker_Therapeutics_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\\\/\",\"name\":\"Marker Therapeutics to Present at Three Upcoming September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/771253\\\/Marker_Therapeutics_Logo.jpg\",\"datePublished\":\"2021-09-07T20:09:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/771253\\\/Marker_Therapeutics_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/771253\\\/Marker_Therapeutics_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Marker Therapeutics to Present at Three Upcoming September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Marker Therapeutics to Present at Three Upcoming September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Marker Therapeutics to Present at Three Upcoming September Investor Conferences - Market Newsdesk","og_description":"PR Newswire HOUSTON, Sept. 7, 2021 \/PRNewswire\/ &#8212;\u00a0Marker Therapeutics, Inc.\u00a0(NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that the Company will present at three upcoming virtual investor conferences in September. Conference Details H.C. Wainwright Annual Global Investment ConferenceCompany Presenter: Anthony H. Kim, Chief Financial OfficerDate: Monday, September 13, 2021Time: On-demand beginning at 7:00 a.m. ET Oppenheimer Fall Healthcare Life Sciences &amp; MedTech SummitCompany Presenter: Mythili Koneru, M.D., Ph.D., Chief Medical OfficerDate: Wednesday, September 22, 2021Time: 9:05 a.m. ET Cantor Fitzgerald Global Healthcare ConferenceFireside Chat Date: Monday, September 27, 2021Time: 10:40 a.m. ET Live webcasts of the presentations will be accessible from the &hellip; Continue reading \"Marker Therapeutics to Present at Three Upcoming September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-07T20:09:42+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/771253\/Marker_Therapeutics_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Marker Therapeutics to Present at Three Upcoming September Investor Conferences","datePublished":"2021-09-07T20:09:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/"},"wordCount":342,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/771253\/Marker_Therapeutics_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/","name":"Marker Therapeutics to Present at Three Upcoming September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/771253\/Marker_Therapeutics_Logo.jpg","datePublished":"2021-09-07T20:09:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/771253\/Marker_Therapeutics_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/771253\/Marker_Therapeutics_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/marker-therapeutics-to-present-at-three-upcoming-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Marker Therapeutics to Present at Three Upcoming September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535128","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=535128"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535128\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=535128"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=535128"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=535128"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}